Stable pharmaceutical composition containing 8-(3r)-3-amino-l-piperidinyl-7-(2-butyn-l-yl)-3,7-di- - hydro-3-methyl-l-(4-methyl-2-quinazolinyl)methyl-lh-purine-2,6-dione or a pharmaceutically acceptable salt thereof

摘要

The present invention relates to a stable pharmaceutical composition comprising amorphous or crystalline linagliptin or a pharmaceutically acceptable salt of linagliptin mannitol copovidone and magnesium stearate processes for preparing the stable pharmaceutical composition and a container comprising the stable pharmaceutical composition.